Title: Design and synthesis of orally-active and selective azaindane 5HT2c agonist for the treatment of obesity.
Journal: Bioorganic & medicinal chemistry letters 20100101
137583-04-1
34803-66-2
50693-78-2
52266-53-2
928026-67-9
1071545-91-9
1268868-36-5 | Benzenemethanol, 3-(phenylmethoxy)-α-[[(phenylmethyl)amino]methyl]- | AA000TCA | MFCD22375390
12002-03-8 | C.I. Pigment Green 21 | AA000TPD | MFCD01751004
13019-22-2 | 9-Decen-1-ol | AA000U1I | MFCD00002992
1304513-50-5 | Trimethyl 3,3',3''-phosphinetriyltripropanoate hydrochloride | AA000UDB | MFCD11505666
1306606-90-5 | 6-bromoquinoline-8-carbaldehyde | AA000UO8 | MFCD11847623
13089-19-5 | α-D-Glucopyranoside, phenyl 2-(acetylamino)-2-deoxy-, 3,4,6-triacetate | AA000UZM | MFCD04039661
1310384-20-3 | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-enecarbonitrile | AA000VAZ | MFCD12025482
13115-71-4 | Glycyl-l-glutamine | AA000VK7 | MFCD00150855
1313738-80-5 | 1-Benzyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine | AA000VY5 | MFCD11840350
1314987-31-9 | 2,4-Dibromo-5-fluorothioanisole | AA000W93 | MFCD19684123